Annual Working Capital
$12.83 M
-$4.14 M-24.38%
December 31, 2023
Summary
- As of February 12, 2025, GANX annual working capital is $12.83 million, with the most recent change of -$4.14 million (-24.38%) on December 31, 2023.
- During the last 3 years, GANX annual working capital has risen by +$5.96 million (+86.66%).
- GANX annual working capital is now -63.52% below its all-time high of $35.17 million, reached on December 31, 2021.
Performance
GANX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$9.15 M
-$2.87 M-23.88%
September 30, 2024
Summary
- As of February 12, 2025, GANX quarterly working capital is $9.15 million, with the most recent change of -$2.87 million (-23.88%) on September 30, 2024.
- Over the past year, GANX quarterly working capital has dropped by -$3.68 million (-28.70%).
- GANX quarterly working capital is now -79.70% below its all-time high of $45.06 million, reached on March 31, 2021.
Performance
GANX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
GANX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.4% | -28.7% |
| 3 y3 years | +86.7% | -74.0% |
| 5 y5 years | - | -74.0% |
GANX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.5% | at low | -74.0% | +22.3% |
| 5 y | 5-year | -63.5% | +2954.0% | -79.7% | +33.1% |
| alltime | all time | -63.5% | +2954.0% | -79.7% | +33.1% |
Gain Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.15 M(-23.9%) |
| Jun 2024 | - | $12.02 M(+35.6%) |
| Mar 2024 | - | $8.86 M(-30.9%) |
| Dec 2023 | $12.83 M(-24.4%) | $12.83 M(+71.6%) |
| Sep 2023 | - | $7.48 M(-36.2%) |
| Jun 2023 | - | $11.72 M(-17.3%) |
| Mar 2023 | - | $14.17 M(-16.5%) |
| Dec 2022 | $16.97 M | $16.97 M(-15.2%) |
| Sep 2022 | - | $20.02 M(-10.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $22.42 M(-30.3%) |
| Mar 2022 | - | $32.17 M(-8.5%) |
| Dec 2021 | $35.17 M(+411.7%) | - |
| Dec 2021 | - | $35.17 M(-7.4%) |
| Sep 2021 | - | $37.98 M(-9.3%) |
| Jun 2021 | - | $41.88 M(-7.0%) |
| Mar 2021 | - | $45.06 M(+555.6%) |
| Dec 2020 | $6.87 M(-1629.0%) | - |
| Dec 2020 | - | $6.87 M |
| Dec 2019 | -$449.50 K | - |
FAQ
- What is Gain Therapeutics annual working capital?
- What is the all time high annual working capital for Gain Therapeutics?
- What is Gain Therapeutics annual working capital year-on-year change?
- What is Gain Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Gain Therapeutics?
- What is Gain Therapeutics quarterly working capital year-on-year change?
What is Gain Therapeutics annual working capital?
The current annual working capital of GANX is $12.83 M
What is the all time high annual working capital for Gain Therapeutics?
Gain Therapeutics all-time high annual working capital is $35.17 M
What is Gain Therapeutics annual working capital year-on-year change?
Over the past year, GANX annual working capital has changed by -$4.14 M (-24.38%)
What is Gain Therapeutics quarterly working capital?
The current quarterly working capital of GANX is $9.15 M
What is the all time high quarterly working capital for Gain Therapeutics?
Gain Therapeutics all-time high quarterly working capital is $45.06 M
What is Gain Therapeutics quarterly working capital year-on-year change?
Over the past year, GANX quarterly working capital has changed by -$3.68 M (-28.70%)